Cargando…
Trends in use of anti-thrombotic agents and outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) managed with an invasive strategy
OBJECTIVE: To analyze trends in utilization of anti-thrombotic agents (ATA) and in-hospital clinical outcomes in non-ST-elevation myocardial infarction (NSTEMI) patients managed with an invasive strategy from 2007 to 2010. METHODS & RESULTS: Using ACTION Registry(®)-GWTG™ data, we analyzed trend...
Autores principales: | Wayangankar, S.A., Roe, M.T., Chen, A.Y., Gupta, R.S., Giugliano, R.P., Newby, L.K., de Lemos, J.A., Alexander, K.P., Sanborn, T.A., Saucedo, J.F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990733/ https://www.ncbi.nlm.nih.gov/pubmed/27543467 http://dx.doi.org/10.1016/j.ihj.2015.09.036 |
Ejemplares similares
-
Acute Pulmonary Edema and NSTEMI
por: Pilgrim, Ashley
Publicado: (2023) -
European NSTEMI guidelines—return of clopidogrel?
por: Dannenberg, Lisa, et al.
Publicado: (2021) -
NSTEMI treatment: should we always follow the guidelines?
por: van ’t Hof, A. W. J., et al.
Publicado: (2019) -
CORONARY CONSIDERATIONS FOR THROMBOSIS IN COVID-19 NSTEMI
por: Wilbanks, David, et al.
Publicado: (2022) -
Early Clopidogrel Versus Prasugrel Use Among Contemporary STEMI and NSTEMI Patients in the US: Insights From the National Cardiovascular Data Registry
por: Sherwood, Matthew W., et al.
Publicado: (2014)